Corona Remedies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Sep 2024 |
|---|---|---|---|
| Revenue | 363.40 | 348.56 | 316.33 |
| Operating Expense | 282.66 | 276.76 | 247.05 |
| Net Profit | 52.15 | 46.40 | 42.98 |
| Net Profit Margin | 14.35 | 13.31 | 13.59 |
| Earning Per Share | 8.53 | 7.59 | 7.03 |
| EBIDTA | 79.13 | 71.61 | 67.04 |
| Effective Tax Rate | 19.63 | 19.92 | 17.52 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 363.40 |
| Operating Expense | 282.66 |
| Net Profit | 52.15 |
| Net Profit Margin | 14.35 |
| Earning Per Share | 8.53 |
| EBIDTA | 79.13 |
| Effective Tax Rate | 19.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,196.42 | 1,014.47 | 884.05 |
| Operating Expenses Annual | 956.44 | 859.74 | 756.07 |
| Operating Profit Annual | 245.91 | 161.19 | 135.03 |
| Interest Annual | 10.60 | 14.44 | 4.27 |
| Depreciation | 15.39 | 12.97 | 11.03 |
| Net Profit Annual | 149.05 | 90.50 | 84.70 |
| Tax Annual | 49.10 | 27.98 | 25.96 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,196.42 |
| Operating Expenses Annual | 956.44 |
| Operating Profit Annual | 245.91 |
| Interest Annual | 10.60 |
| Depreciation | 15.39 |
| Net Profit Annual | 149.05 |
| Tax Annual | 49.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.16 | 14.49 | 6.82 |
| Cash Flow from Operations | 190.49 | 156.76 | 102.70 |
| Cash Flow from Investing | -83.84 | -266.64 | -50.28 |
| Cash Flow from Financing | -106.59 | 98.54 | -44.75 |
| Cash Flow at the End | 3.22 | 3.16 | 14.49 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 3.16 |
| Cash Flow from Operations | 190.49 |
| Cash Flow from Investing | -83.84 |
| Cash Flow from Financing | -106.59 |
| Cash Flow at the End | 3.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 20.55 | 15.89 | 15.27 |
| PBIT Margin (%) | 17.45 | 13.10 | 13 |
| PBT Margin (%) | 15.80 | 12.19 | 9.95 |
| Net PROFIT Margin (%) | 12.46 | 8.92 | 9.58 |
| Return On Networth / Equity (%) | 27.45 | 20.38 | 23.24 |
| Return On Networth /Employed (%) | 29.78 | 23.47 | 27.29 |
| Return On Assets (%) | 21.30 | 15.97 | 20.12 |
| Total Debt / Equity (X) | 0.23 | 0.21 | 0.08 |
| Asset Turnover Ratio (%) | 1.71 | 1.79 | 2.10 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 20.55 |
| PBIT Margin (%) | 17.45 |
| PBT Margin (%) | 15.80 |
| Net PROFIT Margin (%) | 12.46 |
| Return On Networth / Equity (%) | 27.45 |
| Return On Networth /Employed (%) | 29.78 |
| Return On Assets (%) | 21.30 |
| Total Debt / Equity (X) | 0.23 |
| Asset Turnover Ratio (%) | 1.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 369.88 | 383.70 | 184.60 |
| Total Current Assets Annual | 338.87 | 289.92 | 291.49 |
| Non Current Assets Annual | 590.37 | 540.42 | 303.31 |
| Total Shareholders Funds Annual | 605.73 | 480.18 | 408.29 |
| Total Assets Annual | 929.24 | 830.34 | 594.80 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 369.88 |
| Total Current Assets Annual | 338.87 |
| Non Current Assets Annual | 590.37 |
| Total Shareholders Funds Annual | 605.73 |
| Total Assets Annual | 929.24 |
EPS (INR)
Expected
8.55
Reported
8.55
Surprise
0.00%
Jun 2025
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
